Economists are placing hospital pricing and market consolidation at the center of U.S. healthcare cost inflation, a finding with direct implications for independent and network-affiliated dental and medical practices facing rising overhead and insurance reimbursement pressure.

While the full MedPage Today analysis is behind a paywall, the headline finding—that hospital systems' market power and price leverage are primary cost drivers—reflects a decade of consolidation data. Hospital systems now control 50–60% of many regional markets, enabling them to negotiate significantly higher reimbursement rates with payers compared to independent practices. This creates a cost-and-revenue squeeze for standalone practices: hospital-affiliated physicians and dentists access higher negotiating leverage, while non-affiliated providers are squeezed from both sides (lower payer reimbursement, higher operating costs due to lack of scale). For dental practices, this translates to fewer patients with dental insurance (because employers shift to high-deductible plans to offset hospital cost inflation) and lower insurance reimbursement per claim as payers tighten margins to offset hospital overpayments.

Practice owners and DSO executives should interpret this economist consensus as validation of their consolidation rationale: scale matters. Larger networks negotiate better insurance rates, purchase power, and financial sustainability. Smaller independents face structural headwinds. For investors and PE firms, the finding reinforces thesis that dental DSOs (with 100–500 locations) can replicate elements of hospital pricing power—not by raising patient out-of-pocket costs, but by negotiating better insurance rates, capturing more employer plans, and improving operational leverage. The corollary risk: if hospital consolidation is identified as a problem by policymakers (which it is), expect anti-trust scrutiny of DSO roll-ups and PE-driven consolidation.

Watch: Monitor DOJ/FTC enforcement activity around healthcare consolidation over the next 18 months, particularly impact on DSO M&A approval timelines.